-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The country's Ministry of Health and Prevention today announced the registration of a new coronavirus inactivated vaccine developed by the Chinese Pharmaceutical Group's China Bio-Beijing Biological Products Research Institute, the UAE News Agency reported.
's decision was in response to an earlier application by China Biopharmaceutical Co., Ltd., a subsidiary of China National Pharmaceutical Group.
uae's Ministry of Health and Prevention and Abu Dhabi's Ministry of Health have also reviewed phase III clinical trial data submitted by Chinese medicine students, according to the UAE News Agency.
Clinical trials of about 31,000 volunteers with 125 different nationalities showed that the New Coronavirus Inactivated Vaccine, produced in China, was 86% effective against viral infection, with a 99% moderate antibody yang rate and 100% prevention of moderate and severe cases of new coronary pneumonia.
and studies have found no serious safety risks with vaccines.
uae news agency also revealed that the vaccine in September this year in the country has been granted emergency use authorization to protect health care workers fighting on the front line of the outbreak.
follow-up assessment of this emergency use authorization by UAE officials, similar to the clinical trial data provided by Chinese medicine, showed that the vaccine was effective and safe.
content Source: Global Times